Manufacture

Sitting Down With… Andy Skibo, Executive Vice President, Operations at MedImmune, and Chairman of the ISPE.

What’s convenient for manufacturers does not always result in a product that’s best for patients.

Serialization will enable our industry to take up its rightful place in the ‘Internet of Things’.

For the first time, stem cell therapy has been recommended for use in Europe

An ambitious UK sequencing project aims to learn more about patients with cancer and rare diseases

Are vaccines set for a makeover? Two studies from researchers in Massachusetts demonstrate the new approaches that R&D scientists are taking.

Ranking the 100 most influential people in drug development and manufacture.

A group of researchers have used supercomputers to link proteins to drug side effects.

Biologic medicines present unique challenges for pharmacovigilance. And with biosimilars hitting the market, life just got more complicated.

Can a new generation of chromatography techniques and technologies get things moving again?